爱博医疗收盘下跌2.92%，滚动市盈率39.73倍，总市值150.21亿元

Group 1 - The core viewpoint of the article highlights the financial performance and market position of Aibo Medical, indicating a decline in stock price and a comparison with industry averages [1] - Aibo Medical's closing stock price is 79.25 yuan, down 2.92%, with a rolling PE ratio of 39.73 times and a total market capitalization of 15.021 billion yuan [1] - The average PE ratio for the medical device industry is 46.40 times, with a median of 34.81 times, placing Aibo Medical at the 82nd position in the industry ranking [1] Group 2 - As of the first quarter of 2025, 67 institutions hold shares in Aibo Medical, including 62 funds, with a total shareholding of 67.74 million shares valued at 6.637 billion yuan [1] - Aibo Medical specializes in the research, development, production, sales, and related services of ophthalmic medical devices, with key products including artificial lenses and other vision care products [1] - The latest financial results for the first quarter of 2025 show Aibo Medical achieving a revenue of 357 million yuan, a year-on-year increase of 15.07%, while net profit was 92.558 million yuan, reflecting a year-on-year decrease of 10.05%, with a gross profit margin of 64.60% [1]